Vascular devices maker Sahajanand Medical Technologies (SMT) has opened the first phase of its ₹ 250 crore global hub for manufacturing and R&D at Telangana government-promoted Medical Devices Park in Sultanpur, near Hyderabad. Developed on 20 acres, in the first phase the minimally invasive vascular devices facility comprises 2 lakh sq ft of built-up area including 15 clean rooms. On completion of all phases it will be largest such in Asia, the company said at the inauguration of the facility by Industries and IT Minister K.T. Rama Rao on Friday. The R&D centre will focus on developing advanced medical products in interventional, structural, and peripheral vascular interventions, it said.
CEO Ganesh Sabat said the company makes coronary stents, balloon catheters, occluder and valves and has manufacturing units in Surat, Bengaluru as well as Thailand. It intends over time to make all the products at the plant in Telangana. The plan is to make 10 lakh stents and 20 lakh balloon catheters a year. In Surat where its largest facility is located, SMT makes about 7 lakh stents.
Initially balloon catheters will be made followed by stents, at Sultanpur, he said, adding that of the ₹ 250 crore investment proposed, the company has spent ₹ 130 crore on the first phase. In two years, 1,000 people are likely to be employed at the plant here. Complimenting SMT for implementing the project through the pandemic, Mr. Rao said inauguration of the facility is a milestone for the Medical Devices Park. It is a step towards making available high quality, indigenously made, affordable healthcare products from Telangana for a global populace.
